Koers Insuline Medical Ltd TEL AVIV STOCK EXCHANGE
Aandelen
IL0011201618
Geavanceerde medische apparatuur & technologie
Omzet 2022 | -19,47 mln. -5,2 mln. -1,95 mld. -4,86 mln. | Omzet 2023 | -10,94 mln. -2,92 mln. -1,09 mld. -2,73 mln. | Marktkapitalisatie | 11,77 mln. 3,14 mln. 1,18 mld. 2,94 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -25 mln. -6,67 mln. -2,5 mld. -6,24 mln. | Nettowinst (verlies) 2023 | -25 mln. -6,67 mln. -2,5 mld. -6,24 mln. | EV/omzet 2022 | -2,65 x |
Nettoschuld 2022 | 35,92 mln. 9,59 mln. 3,59 mld. 8,97 mln. | Nettoschuld 2023 | 16,36 mln. 4,37 mln. 1,64 mld. 4,08 mln. | EV/omzet 2023 | -2,57 x |
K/w-verhouding 2022 |
-0,62
x | K/w-verhouding 2023 |
-0,47
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 54,41% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 65 | 08-04-18 | |
Gabriel Bitton
FOU | Founder | 61 | 01-01-98 |
David Gerbi
DFI | Director of Finance/CFO | 45 | 03-11-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Gabriel Bitton
FOU | Founder | 61 | 01-01-98 |
Udi Shenig
BRD | Director/Board Member | 57 | 15-03-23 |
Naor Eliyahu
CHM | Chairman | 51 | 08-04-18 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-54,19% | 2,26 mld. | |
+19,59% | 1,89 mld. | |
-8,65% | 1,52 mld. | |
+18,25% | 1,19 mld. | |
-24,23% | 871 mln. | |
+1,69% | 781 mln. | |
-34,22% | 750 mln. | |
-29,46% | 591 mln. | |
+18,16% | 560 mln. |